Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


10.02.2025

2 Anticancer Res
1 BJU Int
1 BMC Cancer
1 BMC Urol
2 Br J Cancer
1 Cancer Res
2 Eur J Radiol
1 Eur Radiol
3 Eur Urol
1 Int J Oncol
6 Int J Radiat Oncol Biol Phys
3 Int J Urol
4 J Nucl Med
1 Proc Natl Acad Sci U S A
1 Urol Int
2 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Res

  1. RADES D, Kristiansen C, Vestergaard Madsen C, Kuter JD, et al
    Bladder Volume <200 ml During a Course of Moderate Hypofractionated Irradiation in Patients With Localized Prostate Cancer.
    Anticancer Res. 2025;45:701-708.
    PubMed         Abstract available

  2. HIROSHIGE T, Suekane H, Tokunaga T, Uegaki M, et al
    Prognostic Stratification Using Early Prostate-specific Antigen Kinetics in Men With Metastatic Hormone-sensitive Prostate Cancer.
    Anticancer Res. 2025;45:751-759.
    PubMed         Abstract available


    BJU Int

  3. RODRIGUEZ-SANCHEZ L, Cathelineau X, de Reijke TM, Stricker P, et al
    Refining partial gland ablation for localised prostate cancer: the FALCON project.
    BJU Int. 2025 Feb 4. doi: 10.1111/bju.16669.
    PubMed         Abstract available


    BMC Cancer

  4. FAN J, Xu K, Jiang Z, Gan C, et al
    Role of (18)F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study.
    BMC Cancer. 2025;25:192.
    PubMed         Abstract available


    BMC Urol

  5. CHARLICK M, Tiruye T, Ettridge K, O'Callaghan M, et al
    Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men's sex life: an analysis of patient reported outcome survey data.
    BMC Urol. 2025;25:21.
    PubMed         Abstract available


    Br J Cancer

  6. WANG R, Wang S, Mi Y, Huang T, et al
    Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study.
    Br J Cancer. 2025 Feb 3. doi: 10.1038/s41416-025-02947.
    PubMed         Abstract available

  7. LIU C, Reger M, Fan H, Wang J, et al
    Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Br J Cancer. 2024 Dec 16. doi: 10.1038/s41416-024-02929.
    PubMed         Abstract available


    Cancer Res

  8. ZHANG C, Ding J, Lim KS, Zhou W, et al
    JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer.
    Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-23-2796.
    PubMed         Abstract available


    Eur J Radiol

  9. PONSIGLIONE A, Stanzione A, Minieri A, Musella R, et al
    Impact of software-assisted structured reporting on radiology residents approaching prostate MRI.
    Eur J Radiol. 2024;183:111889.
    PubMed         Abstract available

  10. WALTER-RITTEL TC, Frisch A, Hamm CA, Baumgartner GL, et al
    Automated 24-sector grid-map algorithm for prostate mpMRI improves precision and efficacy of prostate lesion location reporting.
    Eur J Radiol. 2025;183:111897.
    PubMed         Abstract available


    Eur Radiol

  11. PANEBIANCO V, Catalano C, Sanguedolce F, De Santis M, et al
    ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view.
    Eur Radiol. 2025 Jan 31. doi: 10.1007/s00330-025-11354.
    PubMed        


    Eur Urol

  12. RAVI P, Kwak L, Acosta AM, Rastogi S, et al
    Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer.
    Eur Urol. 2025 Feb 6:S0302-2838(25)00027-2. doi: 10.1016/j.eururo.2025.
    PubMed         Abstract available

  13. CASTRO E, Lorente D, Olmos D
    PARP Inhibitors and Prostate Cancer: The Struggle To Separate the Grain from the Chaff.
    Eur Urol. 2025 Feb 3:S0302-2838(25)00024-7. doi: 10.1016/j.eururo.2025.
    PubMed        

  14. BERNARDINO RM, van der Kwast T, Fleshner NE
    Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives.
    Eur Urol. 2025 Jan 30:S0302-2838(25)00025-9. doi: 10.1016/j.eururo.2025.
    PubMed         Abstract available


    Int J Oncol

  15. MASUD N, Aldahish A, Iczkowski KA, Kale A, et al
    [Retracted] Zinc finger protein?like 1 is a novel neuroendocrine biomarker for prostate cancer.
    Int J Oncol. 2025;66:16.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  16. LANGE M, Campion L, Ollivier L, Renouf M, et al
    Patterns of relapse following radiotherapy of intermediate-risk (IR) prostate cancer (PCa) on the PROFIT randomized trial.
    Int J Radiat Oncol Biol Phys. 2025 Feb 4:S0360-3016(25)00089.
    PubMed         Abstract available

  17. LE REUN E, Espenel S, Garcia MA, Girbovan AH, et al
    Image-Guided Brachytherapy for Pediatric Bladder and/or Prostate Rhabdomyosarcoma: Toward an Increased Personalization of Treatment.
    Int J Radiat Oncol Biol Phys. 2025;121:658-666.
    PubMed         Abstract available

  18. FENG H, Shan J, Vargas CE, Keole SR, et al
    Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based Autosegmentation in Pencil Beam Scanning Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2025;121:822-831.
    PubMed         Abstract available

  19. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    PubMed         Abstract available

  20. REARDON MD, Bibby BAS, Thiruthaneeswaran N, Pereira RR, et al
    Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;121:752-760.
    PubMed         Abstract available

  21. MONINGI S, Orio PF 3rd
    An Aggressive Approach for Mucinous Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2025;121:584.
    PubMed        


    Int J Urol

  22. TOHI Y, Kato T, Kohashiguchi K, Kaji A, et al
    Overuse of imaging in prostate cancer staging.
    Int J Urol. 2025 Feb 3. doi: 10.1111/iju.70003.
    PubMed         Abstract available

  23. HIROSE K, Nakanishi Y, Ogasawara RA, Imasato N, et al
    Risk factors for rectal wall infiltration in hydrogel spacer placement: Influence of biopsy approach.
    Int J Urol. 2025;32:183-189.
    PubMed         Abstract available

  24. MINAMI T, Fujimoto S, Fujita K
    Iodine-125 low-dose rate prostate brachytherapy.
    Int J Urol. 2025;32:130-137.
    PubMed         Abstract available


    J Nucl Med

  25. LINDENBERG L, Hope TA, Lin FI, Rowe SP, et al
    Safety, Dosimetry, and Feasibility of [(68)Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer.
    J Nucl Med. 2025 Feb 6:jnumed.124.268318. doi: 10.2967/jnumed.124.268318.
    PubMed         Abstract available

  26. DERLIN T, Widjaja L, Harke NN, Czerner C, et al
    (99m)Tc-MIP-1404 SPECT/CT Companion Diagnostic for (177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2025 Feb 6:jnumed.124.269319. doi: 10.2967/jnumed.124.269319.
    PubMed         Abstract available

  27. VAN DER GAAG S, Vis AN, Bartelink IH, Koppes JCC, et al
    Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET.
    J Nucl Med. 2025 Feb 6:jnumed.124.268340. doi: 10.2967/jnumed.124.268340.
    PubMed         Abstract available

  28. LAWAL IO, Mushtaq A, Jani AB, Rupji M, et al
    Diuresis During (18)F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial.
    J Nucl Med. 2025 Jan 23:jnumed.124.268574. doi: 10.2967/jnumed.124.268574.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  29. PITZEN SP, Rudenick AN, Qiu Y, Zhang W, et al
    Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2415308122.
    PubMed         Abstract available


    Urol Int

  30. FIORELLO N, Zucchi A, Gregori F, Romei G, et al
    Urinary Leakage after Robot-Assisted Radical Prostatectomy: Is Always Predictive of Functional Results?
    Urol Int. 2025;109:68-73.
    PubMed         Abstract available


    Urology

  31. SHORE N, Armstrong AJ, Barata P, Byrne L, et al
    Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider.
    Urology. 2025 Feb 3:S0090-4295(25)00114-1. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available

  32. RASTER G, Helfand BT
    Aquablation Safety and Outcomes Among Men with Prostate Cancer.
    Urology. 2025 Jan 30:S0090-4295(25)00107-4. doi: 10.1016/j.urology.2025.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.